Dyne Therapeutics NYSE DYN
$28.50 0.0000 0.0000%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 19 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.75B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.63B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

61.39M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

114.29 %
Upcoming events Dyne Therapeutics All events
No upcoming events scheduled

Stock chart Dyne Therapeutics

Stock analysis Dyne Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-7.47 -67.88
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
19.17 2.82
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-6.79 13.03
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.49 7.23
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-256.59 -0.36

Price change Dyne Therapeutics per year

13.50$ 32.32$
Min Max

Summary analysis Dyne Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Dyne Therapeutics

Revenue and net income Dyne Therapeutics

All parameters

About company Dyne Therapeutics

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was founded in 2017 and is headquartered in Waltham, Massachusetts.
Address:
830 Winter Street, Waltham, MA, United States, 02451
Company name: Dyne Therapeutics
Issuer ticker: DYN
ISIN: US26818M1080
Country: USA
Exchange: NYSE
Currency: $
IPO date: 2020-09-17
Sector: Utilities
Industry: Independent Power Producers & Energy Traders
Site: https://www.dyne-tx.com

On which stock exchange are Dyne Therapeutics (DYN) stocks traded?

Dyne Therapeutics (DYN) stocks are traded on NYSE.

What is the ticker of Dyne Therapeutics stocks (DYN)?

The stock ticker of Dyne Therapeutics’s stocks or in other words, the code is DYN. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Dyne Therapeutics (DYN) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Dyne Therapeutics (DYN) belongs to the «Utilities» sector and the «Independent Power Producers & Energy Traders» industry.

In what currency are Dyne Therapeutics (DYN) stocks traded?

Dyne Therapeutics (DYN) stocks are traded on the NYSE exchange in dollars.

What is the price of Dyne Therapeutics (DYN) stocks today?

The current price of Dyne Therapeutics stocks on 28.03.2024 is 28.5 dollars. per share.

What is the dynamics of Dyne Therapeutics (DYN) stocks from the beginning of the year?

Dyne Therapeutics (DYN) quotes have increased by 118.22% from the beginning of the year up to 28.5 dollars. per 1 stocks.

How much did Dyne Therapeutics (DYN) stocks increase in марте 2024?

This month Dyne Therapeutics (DYN) quotes have increased by -2.16% to 28.5 dollars. per share.

How much are Dyne Therapeutics (DYN) stocks worth?

Today, on October, 28.03.2024 Dyne Therapeutics’s (DYN) stocks cost 28.5 dollars..

What is the market capitalization of Dyne Therapeutics (DYN)?

Capitalization is the market value of Dyne Therapeutics (DYN) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 28.03.2024, the market capitalization of Dyne Therapeutics (DYN) is estimated at about 1749712156 dollars.